Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Other Working Capital Changes (2015 - 2017)

Geron's (GERN) quarterly Other Working Capital Changes came in at -$974000.0 in Q2 2026, down 89.13% year-over-year from -$9.0 million in Q2 2025, and down 143.6% quarter-over-quarter from $2.2 million in Q1 2026.

Analysis

Geron (GERN) Other Working Capital Changes (2015 - 2017) Analysis & Trends

Geron has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$974000.0 for Q2 2026.

  • In Q2 2026, Other Working Capital Changes fell 89.13% year-over-year to -$974000.0; the TTM figure through Jun 2026 stood at -$709000.0 (up 16.69% YoY), while the FY2025 annual figure was -$796000.0, down 11.33% from the prior year.
  • Other Working Capital Changes came in at -$974000.0 for Q2 2026 at Geron, down from $2.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $16.1 million in Q3 2023 to a low of -$14.3 million in Q4 2023.
  • Average Other Working Capital Changes over 3 years is $574222.2, with a median of $95000.0 recorded in 2015.
  • The largest YoY upside for Other Working Capital Changes was 3534.9% in 2016 against a maximum downside of 955.79% in 2016.
  • Over 4 years, Other Working Capital Changes stood at -$14.3 million in 2023, then soared by 82.16% to -$2.6 million in 2024, then soared by 75.4% to -$629000.0 in 2025, then slumped by 54.85% to -$974000.0 in 2026.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$974000.0 in Q2 2026, $2.2 million in Q1 2026, and -$629000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.55 Mn
Sep 30, 2017 -5.55 Mn
Jun 30, 2017 -49,000.00
Jun 30, 2017 -49,000.00
Mar 31, 2017 6.00 Mn
Mar 31, 2017 6.00 Mn
Sep 30, 2016 5.42 Mn
Sep 30, 2016 5.42 Mn
Jun 30, 2016 -206,000.00
Jun 30, 2016 -206,000.00
Mar 31, 2016 -813,000.00
Mar 31, 2016 -813,000.00
Sep 30, 2015 149,000.00
Sep 30, 2015 149,000.00
Jun 30, 2015 126,000.00
Jun 30, 2015 126,000.00
Mar 31, 2015 95,000.00
Mar 31, 2015 95,000.00